United States — Memphis, Tennessee

United States is a clinical research site located in Memphis, Tennessee, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

United States has participated in 3 clinical trials.

Therapeutic areas: Epilepsy, Major Depressive Disorder.

Sponsors: UCB Biopharma S.P.R.L., BlackThorn Therapeutics, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Memphis

Browse all research sites in Tennessee · View every site in Memphis

• UTHSC Lebonheur Children's Hospital
• Baptist Memorial Hospital Cancer Center
• Methodist Healthcare - Memphis Hospitals
• University of TN Health Sciences Centre
• Ohio State University-Telemedicine
• Methodist University Hospital/University of Tennessee Health Science Center, Office of Clinical Research
• Memphis Veterans Affairs Medical Center
• Baptist Memphis Hospital
• Baptist Memorial Hospital and Cancer Center-Memphis
• Methodist Hospitals of Memphis
• University of Tennessee CF Care and Research Center
• University of Tennessee Health Science Center; Le Bonheur Children's Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for United States?

United States has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has United States conducted?

United States has 3 clinical trials on record. Their work covers Epilepsy, Major Depressive Disorder.

Is United States accredited by Crixeo Clinical Trials?

United States has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about United States?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.